(AGENPARL) - Roma, 6 Dicembre 2022 - (AGENPARL) – mar 06 dicembre 2022 Update from GOV.?UK for: News and communications Pfizer/BioNTech COVID-19 vaccine authorised for use in infants and children aged 6 months to 4 years Page summary: The Comirnaty COVID vaccine has met the MHRA’s required safety, quality and effectiveness st…
[Go to the GOV.UK homepage](https://www.gov.uk)
GOV.UK
Update from GOV.?UK for:
News and communications
—————————————————————
[Pfizer/BioNTech COVID-19 vaccine authorised for use in infants and children aged 6 months to 4 years](https://www.gov.uk/government/news/pfizerbiontech-covid-19-vaccine-authorised-for-use-in-infants-and-children-aged-6-months-to-4-years?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=caaee108-99f3-434d-8dae-f2dd3e13ffc7&utm_content=immediately)
Page summary:
The Comirnaty COVID vaccine has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
Change made:
First published.
Time updated:
10:59am, 6 December 2022
—————————————————————